Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3962468 | 0.87 | GLO1 (0.52) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL7262 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL9823358 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL1331989 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL295693 | 0.80 | — | — | |
| SCHEMBL7661231 | 0.78 | — | — | |
| SCHEMBL7667031 | 0.78 | — | — | |
| SCHEMBL5871996 | 0.78 | HCAR2 (0.41) | ALDH1A1LMNAGAATSHRSMN1; SMN2 | |
| SCHEMBL3688659 | 0.78 | — | — | |
| SCHEMBL9751764 | 0.78 | ALDH1A1 (0.59) | ALDH1A1LMNAHSD17B10NPSR1GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100069244-A1 | Pyridine Compounds for Combating Pests | BASF SE (DE) | 2010-03-18 | — | — | US | claimed |
| EP-2086325-A1 | PYRIDINE COMPOUNDS FOR COMBATING PESTS | BASF SE (DE) | 2009-08-12 | — | — | EP | claimed |
| WO-2008065145-A1 | PYRIDINE COMPOUNDS FOR COMBATING PESTS | BASF SE (DE) | 2008-06-05 | — | — | WO | claimed |
| EP-1047690-A1 | HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION | Abbott Laboratories (US) | 2000-11-02 | — | — | EP | claimed |
| WO-1999032480-A1 | HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION | ABBOTT LABORATORIES (US) | 1999-07-01 | — | — | WO | claimed |
| EP-3800185-B1 | METHOD FOR MANUFACTURING SALACINOL | FUJIFILM CORP (JP) | 2024-02-14 | — | — | EP | disclosed |
| US-20100069244-A1 | Pyridine Compounds for Combating Pests | BASF SE (DE) | 2010-03-18 | — | — | US | disclosed |
| EP-2086325-A1 | PYRIDINE COMPOUNDS FOR COMBATING PESTS | BASF SE (DE) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008065145-A1 | PYRIDINE COMPOUNDS FOR COMBATING PESTS | BASF SE (DE) | 2008-06-05 | — | — | WO | disclosed |
| US-7071187-B2 | Naphthyridine derivatives | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2006-07-04 | — | — | US | disclosed |
| US-20040214853-A1 | Naphthyridine derivatives | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2004-10-28 | — | — | US | disclosed |
| EP-1426374-A1 | NAPHTHYRIDINE DERIVATIVE | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2004-06-09 | — | — | EP | disclosed |
| EP-0234549-B1 | METHOD FOR PRODUCTION OF CEPHALOSPORIN COMPOUNDS | Takeda Chemical Industries, Ltd. (JP) | 1992-12-16 | — | — | EP | disclosed |
| EP-0187209-B1 | PROCESS FOR THE PREPARATION OF CEPHALOSPORINS | F. HOFFMANN-LA ROCHE AG (CH) | 1992-01-08 | — | — | EP | disclosed |
| US-4980464-A | Method for production of cephalosporin compounds | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-12-25 | — | — | US | disclosed |
| US-4716227-A | Process for manufacturing cephalosporin esters | HOFFMANN-LA ROCHE INC. (US) | 1987-12-29 | — | — | US | disclosed |
| EP-0234549-A2 | Method for production of cephalosporin compounds | Takeda Chemical Industries, Ltd. (JP) | 1987-09-02 | — | — | EP | disclosed |
| EP-0187209-A2 | Process for the preparation of cephalosporins | F. HOFFMANN-LA ROCHE AG (CH) | 1986-07-16 | — | — | EP | disclosed |
| US-4595532-A | N-(substituted-methyl)-azetidin-2-ones | UNIVERSITY OF NOTRE DAME DU LAC (US) | 1986-06-17 | — | — | US | disclosed |
| EP-0116432-A2 | Improvements in or relating to N-(substituted-methyl)-azetidin-2-ones | THE UNIVERSITY OF NOTRE DAME DU LAC (US) | 1984-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214853-A1 | Naphthyridine derivatives | MT-ND1, OPRD1, NR0B1 | ALDH1A1 272/4885LMNA 2666/4885HSD17B10 2101/4885 |
| US-20100069244-A1 | Pyridine Compounds for Combating Pests | CHRM1, PRDX1, CHRM2 | ALDH1A1 1958/4885LMNA 3402/4885HSD17B10 3403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.